Clinical trial Recruiting at 1 site Observational Ages 18 to 65 Women only

Sexual functioning in trans men during gender affirmation

Official title: Evaluating Sexual Functioning in Trans Men During the Gender Affirmation Process: A Mixed Methods Study

Run by Eskisehir Osmangazi University · NCT07131267 · Data updated 2026-11-12

This study will see if sexual functioning changes for trans men with gender dysphoria who are receiving medical gender-affirming care in Türkiye.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexWomen only
Enrollment52 (estimated)
SponsorEskisehir Osmangazi University
Academic / other
Locations1 site (Eskişehir, Türkiye)
StatusRecruiting
StartedAugust 5, 2025
Main results expectedApril 30, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 20, 2025
Trial IDNCT07131267 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are trans men aged 18–65 diagnosed with gender dysphoria by two physicians who are currently receiving medical support for gender affirmation.

Probably not a fit

People over 65, those with intellectual disability, dementia, organic mental disorders, systemic illnesses that impair sexual function, or a Clinical Global Impression score above 3 may not benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This mixed-methods project combines a quantitative survey of 52 trans men using standardized scales with in-depth qualitative interviews of 12 participants about their sexual experiences during gender affirmation. Quantitative measures include the Arizona Sexual Experiences Scale, Sexual Desire Inventory, Utrecht Gender Dysphoria Scale, DASS-21, and the WHOQOL sexual quality of life subscale, along with a sociodemographic and clinical form. The qualitative component uses semi-structured questions to capture personal, cultural, and contextual aspects of sexual functioning during the transition process. Recruitment and data collection occur at Eskişehir Osmangazi University in Türkiye with defined inclusion and exclusion criteria to focus on adult trans men receiving medical support for gender affirmation.

Why it matters

Potential benefit: If successful, the study could clarify how medical gender-affirming care relates to sexual function and help clinicians provide better sexual health support tailored to trans men in Türkiye.

How similar studies have gone: Some international studies have reported changes in sexual functioning after gender-affirming treatment, but this mixed-methods approach is the first of its kind reported in Türkiye.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

18 years or older Diagnosed with gender dysphoria by two different physicians Getting medical support for the gender affirmation process

Exclusion Criteria:

Over 65 years Diagnosed with intellectual disability, dementia, or organic mental disorders Having a systemic disease that negatively impacts sexual function Getting a score above 3 on the Clinical Global Impression Scale

Where it's running

  • Eskişehir Osmangazi University, Faculty of Medicine, Department of Psychiatry
    Eskişehir, Türkiye, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.